Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAG | P20916 | 11/20 | 0.64 |
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.59 |
| ▸ | SELL | P14151 | 1/20 | 0.56 |
| ▸ | SELP | P16109 | 1/20 | 0.56 |
| ▸ | SELE | P16581 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29809799 | 0.97 | SIGLEC7 (0.63) | MAGSIGLEC7SELLSELPSELE | |
| SCHEMBL29790139 | 0.97 | SIGLEC7 (0.63) | MAGSIGLEC7SELLSELPSELE | |
| SCHEMBL21318923 | 0.96 | MAG (0.62) | MAGSIGLEC7SELLSELP | |
| SCHEMBL8673965 | 0.96 | MAG (0.62) | MAGSIGLEC7SELLSELP | |
| SCHEMBL21318889 | 0.96 | MAG (0.62) | MAGSIGLEC7SELLSELP | |
| SCHEMBL29395515 | 0.96 | MAG (0.61) | MAGSIGLEC7SELLSELPSELE | |
| SCHEMBL23857822 | 0.92 | MAG (0.62) | MAGSIGLEC7SELLSELPSELE | |
| SCHEMBL29361397 | 0.92 | MAG (0.62) | MAGSIGLEC7SELLSELPSELE | |
| SCHEMBL29454799 | 0.92 | SELP (0.62) | MAGSIGLEC7SELLSELPSELE | |
| SCHEMBL29449201 | 0.91 | SIGLEC7 (0.66) | MAGSIGLEC7SELLSELPSELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 754 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3620510-B2 | FERMENTATIVE PRODUCTION OF OLIGOSACCHARIDES BY TOTAL FERMENTATION UTILIZING A MIXED FEEDSTOCK | CHR HANSEN HMO GMBH (DE) | 2026-05-27 | — | — | EP | claimed |
| CN-122090639-A | Municipal engineering construction scheme optimization method and system based on artificial intelligence | — | 2026-05-26 | — | — | CN | claimed |
| US-20260139285-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | INBIOSE N V (BE) | 2026-05-21 | — | — | US | claimed |
| US-12600997-B2 | Fermentative production of sialylated saccharides | CHR. HANSEN A/S (DK) | 2026-04-14 | — | — | US | claimed |
| US-20260077013-A1 | COMBINATIONS FOR USE IN CANCER THERAPY | LISATA THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | claimed |
| US-20260062726-A1 | HYBRID METHOD FOR PRODUCING COMPLEX HMOS | DSM IP ASSETS BV (NL) | 2026-03-05 | — | — | US | claimed |
| EP-4702138-A1 | PRODUCTION OF A NEGATIVELY CHARGED OLIGOSACCHARIDE BY A CELL | Inbiose N.V. (BE) | 2026-03-04 | — | — | EP | claimed |
| EP-4686760-A1 | SIALYLTRANSFERASES FOR THE SYNTHESIS OF SIALYLATED GLYCANS, GLYCOCONJUGATES AND GLYCOPROTEINS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-02-04 | — | — | EP | claimed |
| EP-4662305-A1 | PRODUCTION OF A DISACCHARIDE AND/OR MILK OLIGOSACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF UDP-GLCNAC | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | claimed |
| EP-4661697-A1 | NUTRITIONAL COMPOSITION WITH IMPROVED SEGREGATION RESISTANCE | N.V. Nutricia (NL) | 2025-12-17 | — | — | EP | claimed |
| CN-111524535-B | Feature fusion method for speech emotion recognition based on attention mechanism | 杭州电子科技大学 | 2022-06-21 | — | — | CN | claimed |
| WO-2022119982-A2 | MODULAR GLYCAN PRODUCTION WITH IMMOBILIZED BIONANOCATALYSTS | ZYMTRONIX CATALYTIC SYSTEMS, INC. (US) | 2022-06-09 | — | — | WO | claimed |
| CN-114555780-A | Production of a biological product in a host cell | 因比奥斯公司 | 2022-05-27 | — | — | CN | claimed |
| CN-114442637-A | Unmanned vehicle local dynamic obstacle avoidance path planning method | 北京理工大学 | 2022-05-06 | — | — | CN | claimed |
| EP-3980435-A1 | PURIFICATION OF OLIGOSACCHARIDES FROM A FERMENTATION BROTH BY USING FILTRATION | Chr. Hansen HMO GmbH (DE) | 2022-04-13 | — | — | EP | claimed |
| US-11274325-B2 | Sialyltransferases and uses thereof | Glycosyn LLC (US) | 2022-03-15 | — | — | US | claimed |
| US-20220064686-A1 | USE OF SUBSTRATE IMPORTERS FOR THE EXPORT OF OLIGOSACCHARIDES | GINKGO BIOWORKS, INC | 2022-03-03 | — | — | US | claimed |
| WO-2022046501-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER | INTRINSIC MEDICINE, INC. (US) | 2022-03-03 | — | — | WO | claimed |
| WO-2022036225-A1 | HUMAN MILK OLIGOSACCHARIDE COMPOSITIONS FOR USE WITH BACTERIOTHERAPIES | PROLACTA BIOSCIENCE, INC. (US) | 2022-02-17 | — | — | WO | claimed |
| US-20220022515-A1 | Composition, Food Supplement and Method for Supporting and/or Improving Intestinal Health | NUTRIBAM BV (BE) | 2022-01-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260077013-A1 | COMBINATIONS FOR USE IN CANCER THERAPY | MUC1, RNASE1, NEU4 | MAG 2375/4885SIGLEC7 871/4885SELL 694/4885 |
| US-12600997-B2 | Fermentative production of sialylated saccharides | RNGTT, NANS, ENGASE | MAG 1383/4885SIGLEC7 250/4885SELL 1815/4885 |
| US-20260062726-A1 | HYBRID METHOD FOR PRODUCING COMPLEX HMOS | FUCA1, GMDS, MANBA | MAG 2423/4885SIGLEC7 474/4885SELL 2472/4885 |
| US-20260139285-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | GALNT3, NANS, ENGASE | MAG 1618/4885SIGLEC7 512/4885SELL 599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.